306 related articles for article (PubMed ID: 29393039)
21. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
[TBL] [Abstract][Full Text] [Related]
23. Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.
Chung ST; Haymond MW
J Diabetes Sci Technol; 2015 Jan; 9(1):44-51. PubMed ID: 25160667
[TBL] [Abstract][Full Text] [Related]
24. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
Lorenzi M; Bohannon N; Tsalikian E; Karam JH
West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
[TBL] [Abstract][Full Text] [Related]
25. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.
Rossetti P; Porcellati F; Bolli GB; Fanelli CG
Diabetes Care; 2008 Feb; 31 Suppl 2():S113-20. PubMed ID: 18227470
[No Abstract] [Full Text] [Related]
26. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
[TBL] [Abstract][Full Text] [Related]
27. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Pontiroli AE; Ceriani V
Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
[TBL] [Abstract][Full Text] [Related]
28. Nocturnal hypoglycemia in patients with insulin-treated diabetes.
Yale JF
Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S41-6. PubMed ID: 15315870
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
[TBL] [Abstract][Full Text] [Related]
30. Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
Shirin A; Della Rossa F; Klickstein I; Russell J; Sorrentino F
PLoS One; 2019; 14(3):e0213665. PubMed ID: 30893335
[TBL] [Abstract][Full Text] [Related]
31. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus.
White M; Zacharin MR; Werther GA; Cameron FJ
Pediatr Diabetes; 2016 Feb; 17(1):66-9. PubMed ID: 25229989
[TBL] [Abstract][Full Text] [Related]
32. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
Landstedt-Hallin L; Adamson U; Lins PE
J Clin Endocrinol Metab; 1999 Sep; 84(9):3140-5. PubMed ID: 10487677
[TBL] [Abstract][Full Text] [Related]
33. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
34. Closed-loop system in the management of diabetes: past, present, and future.
Shah VN; Shoskes A; Tawfik B; Garg SK
Diabetes Technol Ther; 2014 Aug; 16(8):477-90. PubMed ID: 25072271
[TBL] [Abstract][Full Text] [Related]
35. Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.
El Youssef J; Castle JR; Bakhtiani PA; Haidar A; Branigan DL; Breen M; Ward WK
Diabetes Care; 2014 Nov; 37(11):3054-60. PubMed ID: 25139882
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of glucose-responsive insulin and glucagon delivery on exercise-induced hypoglycaemia among adults with type 1 diabetes mellitus: A meta-analysis of randomized controlled trials.
Lei M; Ling P; Ni Y; Chen D; Wang C; Yang D; Yang X; Xu W; Yan J
Diabetes Obes Metab; 2024 Apr; 26(4):1524-1528. PubMed ID: 38149727
[No Abstract] [Full Text] [Related]
37. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
[TBL] [Abstract][Full Text] [Related]
38. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.
Seaquist ER; Dulude H; Zhang XM; Rabasa-Lhoret R; Tsoukas GM; Conway JR; Weisnagel SJ; Gerety G; Woo VC; Zhang S; Carballo D; Pradhan S; Piché CA; Guzman CB
Diabetes Obes Metab; 2018 May; 20(5):1316-1320. PubMed ID: 29504662
[TBL] [Abstract][Full Text] [Related]
39. A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart.
Tone A; Shikata K; Nakagawa K; Hashimoto M; Makino H
Diabetes Res Clin Pract; 2008 Sep; 81(3):e15-6. PubMed ID: 18676048
[No Abstract] [Full Text] [Related]
40. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
